The localization of surfactant protein (SP), A, B, C, and D mRNAs was examined in B6C3F 1 mice in the normal lung, and in a range of spontaneous proliferative lung lesions using nonisotopic in situ hybridization (ISH). The aim was to develop diagnostic markers, and if possible, throw further light on the histogenesis of these lesions. Tissues from 21 animals were examined, the lesions studied were: 4 alveolar epithelial hyperplasias, 12 alveolar/bronchiolar (A/B) adenomas, and 5 A/B carcinomas. Lung metastases of hepatocellular carcinoma (HCC) were used as controls. In the nonneoplastic lung, staining for SP A, B, and C mRNA was observed in normal and hyperplastic type II cells but not in the bronchiolar epithelium. SP mRNAs were present in all lung tumors, with SPs A, B, and C being coexpressed in 10/12 (83%) of adenomas and 4/ 5 (80%) of carcinomas in both solid and tubulopapillary areas. No signals for SP D mRNA were noted in normal or neoplastic lung. Additionally, no staining for any SP transcript was observed in the HCC metastases examined. In summary, ISH for SP A, B, or C mRNA was a helpful aid in the diagnosis of proliferative lesions of the murine lung, enabling differentiation from hepatocellular metastases. Furthermore, this work provides strong support for the proposal that spontaneous lung tumors in B6C3F 1 mice are of alveolar, not bronchiolar origin, and consistently show type II cell differentiation. We suggest that such tumors should be referred to as alveolar adenomas and carcinomas.
Alveolar/bronchiolar (A/B) adenomas and carcinomas are the most common spontaneous neoplasms of the lung in B6C3F 1 mice. In addition, the lung is one of the most frequent sites of metastases from extrathoracic tumors, in particular hepatocellular carcinoma (HCC). These metastases are sometimes difficult to distinguish from primary lung tumors on routine histologic examination. The histogenesis of spontaneous murine pulmonary tumors has been the subject of much debate, as to whether they arise from type II alveolar cells or from bronchiolar cells. 3 Current beliefs seem to be that these tumors can arise from either of these cell types. 3, 14 Surfactant proteins (SPs) constitute approximately 10% of the total surfactant mixture, with phospholipids comprising the predominant component. To date, two classes of proteins have been identified in humans and other species including mice. SP B and SP C comprise one class and are hydrophobic proteins that help facilitate the spreading and stability of the surfactant film. The second class includes SP A and SP D, which are structurally related hydrophilic collagenous glycoproteins. SP A is believed to be involved in the reg-ulation of surfactant secretion and clearance but the role of SP D has not been established. SPs A and D have also been suggested to be involved in pulmonary defense mechanisms such as opsonization. 17, 19 The four SPs are generally reported to be synthesized by alveolar type II cells and bronchiolar cells. 6, 11, 19 The specific bronchiolar cell type responsible for the production of SPs is thought to be the Clara cell, although recently this has been questioned in the case of SP A synthesis. 15 In situ hybridization (ISH) studies, utilizing isotopic techniques in normal mice, describe the presence of mRNA for SPs A, C, and D in type II cells, 6, 11, 19 and mRNA for SPs A and D in bronchiolar epithelium. 11, 19 SP expression recently has been used as a diagnostic marker in human surgical pathology. SPs A and B were demonstrated by ISH in human lung adenocarcinomas and the authors stated that the procedure may facilitate the differentiation of primary lung neoplasms from metastatic tumors or mesothelioma. 4, 10 In addition, reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect SP mRNAs in human metastatic pulmonary carcinomas. 2 To our knowledge, no reports have yet been published on the use of molecular techniques to show SP mRNA expression in animal tumors.
We decided to develop nonisotopic ISH to study the pattern of SP expression in normal lung and compare it with that seen in hyperplastic and primary neoplastic pulmonary lesions in B6C3F 1 mice. Our aim was to develop diagnostic markers to differentiate primary and metastatic lung lesions and, if possible, determine the cell of origin of the primary tumors.
Materials and Methods

Probes
Five 30-base cDNA oligonucleotide probes, complimentary to the murine SP mRNA sequences were synthesized (R&D Ltd., Abingdon, Oxford, UK) and purified by highpressure liquid chromatography 1 ( Table 1 ). One probe was produced for each of SPs A, B, and C, 5, 9, 11 and two probes were synthesized for SP D. 12 The probes were labeled at both the 5Ј and 3Ј ends with a single molecular of digoxigenin (Boehringer, Lewes, East Sussex, UK).
Tissues
All tissues came from a 2-year background oncogenicity study involving untreated B6C3F 1 mice ( Table 2) . Sixty-six percent of the mice survived the 2-year study period with the remainder being killed for humane reasons at ages ranging between 12 and 23 months. The mice were fed a conventional rodent diet (Rat & Mouse Number 1, Expanded Maintenance Diet, Special Diets Services, Witham, Essex, UK) and drank water ad libitum throughout the study. Twenty-one males were selected with the following diagnoses: 4 mice with alveolar epithelial hyperplasia, 12 with A/B adenoma, and 5 with A/B carcinoma ( Table 2) . Diagnoses were made in accordance with The National Toxicology Program (NTP) histomorphologic classification scheme. 7 In each case sufficient normal lung tissue was present, in addition to the lesion, for the evaluation of bronchioles and lung parenchyma. Lung metastases of HCC were selected from several mice. All HCCs were positive by ISH for albumin mRNA, which has been shown to be a useful diagnostic marker for liver tumors, both primary and secondary. 13 In addition, the following normal tissues were examined: spleen, heart, kidney, brain, liver, stomach, and small intestine.
Tissue specimens were immersion fixed in 10% neutral buffered formalin for varying periods up to 1 month before being dehydrated through graded ethanol and xylene and embedded in paraffin wax. Three-micrometer-thick sections were cut and mounted on silanized slides.
Hybridization
The protocol used for ISH was based on that described elsewhere. 8, 13 After rehydration, sections were pretreated in proteinase K (1 g/ml for 40 minutes at 37 C) and subsequently placed in a non-formamide-containing prehybridization buffer (4ϫ Denhardt's solution, 4ϫ standard saline citrate (SCC), 83 g/ml salmon testes DNA, 5 mg/ml sodium dodecyl sulfate, 4 mg/ml sodium pyrophosphate, 0.01 M tris-HCl) for 1 hour at 42 C. The hybridization was carried out with the appropriate probe (0.3 ng/l) diluted in this buffer overnight in a moist chamber at 42 C. After washing in graded SSC, bound probe was localized with alkaline phosphatase-linked anti-digoxigenin antibody (Boehringer, 1 : 500 dilution) for 1 hour. The final detection step was carried out overnight using nitroblue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP). After dehydration and mounting, slides were examined and photographed using a Zeiss Axioskop microscope (Welwyn Garden City, Hertfordshire, UK). A positive signal was demonstrated by the presence of dark purple or black diformazan cytoplasmic reaction product. Control sections were either pretreated with RNAse A (100 g/ml) before hybridization with labeled probes, hybridized with inappropriate probes of similar length and C : G ratio (Escherichia coli, cytosine deaminase, three 30-mer oligo-probe cocktail; R&D), or hybridized in the absence of labeled probes.
Results
Normal lung
SP mRNAs were consistently present in normal lung in scattered individual cells whose number, distribution, and morphology identified them as alveolar type II cells. In 19/21 (90%) of mice, the type II cells stained positively for mRNA for SPs A, B, and C (Table 3). Although interanimal variation was observed in the staining intensity of the cells with each probe, generally the strongest staining was for SP C mRNA (Fig.  1) . No signals for SP D were noted in any of the lungs examined and therefore a second probe was designed and tested; however, this also gave completely negative results. No staining of bronchi or bronchioles was observed with probes for SPs A, B, C, or D. Other alveolar cells, including macrophages, were also negative. All controls were consistently negative, including normal lung sections hybridized for albumin mRNA.
Alveolar epithelial hyperplasia
Alveolar epithelial hyperplasia comprised discrete, well-localized areas of the lung where the alveolar septae were lined by polyhedral cells with overall retention of the alveolar architecture. Only four such lesions were identified in this study and all expressed SPs (Table 2). Although SP A and SP C mRNAs were present in all these lesions, SP B transcripts were seen in only 2/4. The number of cells staining positively for SP C mRNA was greater than for the other transcripts (Fig.  2) . No staining for SP D mRNA was noted in the hyperplasias.
A/B adenomas and carcinomas
Adenomas and carcinomas were located randomly within the lung parenchyma in both peribronchiolar and peripheral regions. Adenomas were composed of solid, tubulopapillary, or mixed (combination of both) histologic patterns, whereas carcinomas were exclu- sively tubulopapillary. In some areas the carcinomas invaded bronchiolar walls and extended into bronchiolar lumina (mice Nos. 19, 20, and 21); however, no morphologic evidence existed that such tumors had arisen directly within the bronchioles. In particular in no animals was there clear evidence of preneoplastic (dysplastic) or early neoplastic epithelial changes contiguous with, or extending from, the adjacent normal bronchiolar epithelium. SP mRNAs were expressed in all adenomas and carcinomas ( Table 2) with SPs A, B, and C being coexpressed in 10/12 (83%) of adenomas and 4/5 (80%) of carcinomas in both solid and tubulopapillary areas (Figs. 3-6 ).
Interanimal variation in the staining intensity of tumor cells with the same probe was again observed. Generally, the number of cells staining positively for SP C mRNA was greater than for the other transcripts in both solid and tubulopapillary areas. No differences in staining pattern were noted between neoplasms in peribronchiolar regions and distal airways. SP D mRNA was not observed in any of the primary lung tumors. None of the tumors were positive with any of the control procedures and no ISH signals for albumin mRNA were present.
HCC metastases
No positive staining for SP mRNA was observed in the lung metastases of HCC (Fig. 5) ; however, all of the lesions were positive with the albumin probes.
Normal nonpulmonary tissues
No SP expression was seen in other normal tissues as listed above. Focal staining of the splenic red pulp was obtained following hybridization with SP probes. However, this staining was also present in control sections and was attributed to the presence of hemosiderin pigment.
Discussion
In the normal murine lung we localized SP expression in all animals studied, and in all cases the mRNA was confined to cells with the morphology and distribution of alveolar type II cells. SP C mRNA was identified in all animals and, in the majority of cases, gave stronger staining than SP A or B, which were present in 19/21 and 20/21 animals, respectively. No SP D mRNA was observed in any animal.
In general the staining intensity of type II cells with the SP A, B, and C probes varied considerably between animals. We suspect that this was due to factors such as the duration of fixation, rather than to true interanimal variation, as prolonged fixation is known to diminish ISH reactivity. 18 We considered the possibility that the absence of staining for SP D was a technical failure and therefore designed a second probe. This also gave entirely negative results, suggesting that the levels of mRNA were below detectable levels with our methods. We therefore conclude that the main source of SPs in the normal murine lung is the type II cell and that SPs A, B, and C are present in the great majority of these cells. We also consider that SP D mRNA is either not produced or is produced at low and undetectable levels.
Pulmonary tumors are relatively common in many mouse strains. In the NTP historical database, spontaneous A/B tumors occur with overall combined (benign and malignant) incidences of 19.1% in males and 7.3% in females. 7 The histogenesis of these neoplasms has been the subject of much debate, as to whether they arise from type II alveolar cells or bronchiolar cells. 3 Because the cell(s) of origin is debatable, the NTP classifies adenomas or carcinomas originating in the lung with the prefix ''alveolar/bronchiolar'' (A/B). 7 Our finding that all cells in the normal lung expressing high levels of SP mRNA are the type II cells, and that the cells of alveolar hyperplasias, A/B adenomas, and A/B carcinomas all express SP mRNA, demonstrates that the lesions are showing a type II cell pattern of differentiation, and supports the view that these lesions originate from type II cells or from a type II precursor cell. The fact that the tumors show a very similar pattern of distribution of the different SP types is also in keeping with this view. Tumors rarely, if ever, show a consistently higher level of differentiation than normal cells, and in this situation we consider that these lesions are not derived from bronchiolar cells, and should be referred to as alveolar adenomas and carcinomas. The similar pattern of expression of the different types of SPs in the adenomas and carcinomas is consistent with suggestions that the carcinomas are derived by progression from the adenomas, 14 but does not exclude a separate origin.
ISH and immunocytochemistry (ICC) are regarded as complementary techniques, identifying the site of synthesis and storage of a peptide, respectively. Other workers have performed ICC to localize SPs and Clara cell antigen (CCA) in murine lung tumors. 14, 16 These earlier studies were carried out using a general antiserum to surfactant apoproteins and individual SPs could not be discriminated. Such studies failed to demonstrate CCAs but did reveal SPs in the tumors. Therefore, both SP mRNAs and peptides have now been demonstrated in normal type II cells and the tumors, confirming the view that they are alveolar in origin.
The essence of a diagnostic histopathologic marker is that it should be expressed in the disease process with a high degree of specificity. We are not aware that mRNAs for SPs A, B, and C have been detected in normal murine extrapulmonary tissues by any molecular assay. However, RT-PCR and northern blot analysis showed that the SP D gene is expressed in murine heart, stomach, and kidney, in addition to lung. 12 Also, in one study of metastatic human tumors, although SP A and SP C were restricted to metastases of lung origin, SP D was found in a small number of metastases of nonpulmonary adenocarcinomas using RT-PCR. 2 RT-PCR is a technique of great sensitivity, and we do not believe that this affects the validity of our conclusions on the histogenesis of these lesions. However, it does suggest that it would be prudent not to utilize SP D as a lung tumor marker. In our work no SP signals were observed in lung metastases of HCC or in the normal nonpulmonary tissues examined.
In summary, the presence of mRNA for SPs A, B, and C in 100% of murine pulmonary neoplasms suggests that these markers may be useful in the diagnosis of such tumors either in primary or metastatic sites. For diagnostic purposes, a cocktail of probes against SPs A, B, and C has subsequently given excellent results in our laboratory, and will be a useful marker of the alveolar origin of tumors, particularly when combined with albumin probes to establish hepatic origin. The SP probes could possibly be utilized to differentiate treatment-related from spontaneous lung neoplasms, although further work is needed on the pattern of SP expression following tumor induction. SP staining may also be of value in the study of alveolar injury and repair. This work therefore has provided evidence that spontaneous A/B lung tumors in the B6C3F 1 mice are of alveolar origin and consistently show type II cell differentiation. It was shown that SP probes are a helpful diagnostic aid in the recognition of these tumors.
